Literature DB >> 17084521

Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells.

Martin Michaelis1, Jaroslav Cinatl, Puja Anand, Florian Rothweiler, Rouslan Kotchetkov, Andreas von Deimling, Hans W Doerr, Kuslima Shogen, Jindrich Cinatl.   

Abstract

The efficacy of Onconase on the growth of a panel of chemosensitive and chemoresistant neuroblastoma cell lines was investigated. Onconase decreased cell viability of chemosensitive (IMR-32, UKF-NB-3) and chemoresistant neuroblastoma cell lines characterised by high expression of P-glycoprotein (P-gp) (UKF-NB-3(r)DOX(20)) or by high P-gp expression in combination with mutated p53 (UKF-NB-3(r)VCR(10), Be(2)-C), in a similar manner. Moreover, Onconase caused cell cycle block in G1 phase and induced caspase-independent cell death. Transmission electron microscope investigations suggested that Onconase-induced autophagy contributes to Onconase-induced cell death. Antitumour activity of Onconase against naïve and drug-resistant neuroblastoma xenografts was confirmed in animals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084521     DOI: 10.1016/j.canlet.2006.09.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

Review 1.  Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.

Authors:  Marta Menegazzi; Giovanni Gotte
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

Review 2.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 3.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

4.  Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastoma.

Authors:  Tom Van Maerken; Devanand Sarkar; Frank Speleman; Paul Dent; William A Weiss; Paul B Fisher
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 5.  New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.

Authors:  Nina F Schor
Journal:  Pharmacol Ther       Date:  2009-01-23       Impact factor: 12.310

6.  miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells.

Authors:  A A Takwi; Y-M Wang; J Wu; M Michaelis; J Cinatl; T Chen
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

7.  A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.

Authors:  Jessica Castro; Marc Ribó; Susanna Navarro; Maria Victòria Nogués; Maria Vilanova; Antoni Benito
Journal:  BMC Cancer       Date:  2011-01-11       Impact factor: 4.430

8.  Identification of miRNAs contributing to neuroblastoma chemoresistance.

Authors:  Duncan Ayers; Pieter Mestdagh; Tom Van Maerken; Jo Vandesompele
Journal:  Comput Struct Biotechnol J       Date:  2015-04-29       Impact factor: 7.271

9.  Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.

Authors:  Camillo Porta; Chiara Paglino; Luciano Mutti
Journal:  Biologics       Date:  2008-12

10.  Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

Authors:  Martin Michaelis; Denise Klassert; Susanne Barth; Tatyana Suhan; Rainer Breitling; Bernd Mayer; Nora Hinsch; Hans W Doerr; Jaroslav Cinatl; Jindrich Cinatl
Journal:  Mol Cancer       Date:  2009-09-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.